As of 2024-12-13, the Relative Valuation of Ionis Pharmaceuticals Inc (IONS) is (35.85) USD. This relative valuation is based on P/E multiples. With the latest stock price at 36.61 USD, the upside of Ionis Pharmaceuticals Inc based on Relative Valuation is -197.9%.
The range of the Relative Valuation is (34.54) - (35.45) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.8x - 15.6x | 15.2x |
| Forward P/E multiples | 15.2x - 17.5x | 16.4x |
| Fair Price | (34.54) - (35.45) | (35.85) |
| Upside | -194.3% - -196.8% | -197.9% |
| Date | P/E |
| 2024-12-13 | -16.11 |
| 2024-12-12 | -16.29 |
| 2024-12-11 | -16.72 |
| 2024-12-10 | -16.84 |
| 2024-12-09 | -16.98 |
| 2024-12-06 | -16.77 |
| 2024-12-05 | -16.17 |
| 2024-12-04 | -16.35 |
| 2024-12-03 | -15.76 |
| 2024-12-02 | -15.89 |
| 2024-11-29 | -15.72 |
| 2024-11-27 | -15.80 |
| 2024-11-26 | -15.57 |
| 2024-11-25 | -15.60 |
| 2024-11-22 | -14.97 |
| 2024-11-21 | -14.94 |
| 2024-11-20 | -15.58 |
| 2024-11-19 | -14.85 |
| 2024-11-18 | -14.84 |
| 2024-11-15 | -15.11 |
| 2024-11-14 | -16.38 |
| 2024-11-13 | -16.63 |
| 2024-11-12 | -16.62 |
| 2024-11-11 | -17.11 |
| 2024-11-08 | -17.25 |
| 2024-11-07 | -16.92 |
| 2024-11-06 | -17.18 |
| 2024-11-05 | -17.07 |
| 2024-11-04 | -16.92 |
| 2024-11-01 | -17.06 |
| 2024-10-31 | -16.89 |
| 2024-10-30 | -17.28 |
| 2024-10-29 | -17.47 |
| 2024-10-28 | -17.76 |
| 2024-10-25 | -17.25 |
| 2024-10-24 | -17.06 |
| 2024-10-23 | -16.91 |
| 2024-10-22 | -17.02 |
| 2024-10-21 | -17.16 |
| 2024-10-18 | -17.46 |
| 2024-10-17 | -16.94 |
| 2024-10-16 | -17.23 |
| 2024-10-15 | -16.65 |
| 2024-10-14 | -17.00 |
| 2024-10-11 | -16.92 |
| 2024-10-10 | -16.70 |
| 2024-10-09 | -16.75 |
| 2024-10-08 | -16.63 |
| 2024-10-07 | -16.66 |
| 2024-10-04 | -16.68 |